ENDRA Life Sciences Inc Cash Flow Conversion Efficiency
ENDRA Life Sciences Inc cash flow conversion efficiency. Based on the latest financial reports, ENDRA Life Sciences Inc (NDRA) has a cash flow conversion efficiency ratio of -0.147x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-927.56K) by net assets ($6.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ENDRA Life Sciences Inc (2014–2025)
Cash flow conversion efficiency of ENDRA Life Sciences Inc from 2014 to 2025. This chart illustrates how ENDRA Life Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ENDRA Life Sciences Inc (NDRA) share price today for real-time trading data and today's change.
ENDRA Life Sciences Inc Cash Flow Conversion Ratio Explained
ENDRA Life Sciences Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ENDRA Life Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ENDRA Life Sciences Inc ranked by their cash flow conversion efficiency. Also see market cap of ENDRA Life Sciences Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NGS Group AB (publ)
ST:NGS
|
0.030x |
|
Sintex Plastics Technology Limited
NSE:SPTL
|
-11.870x |
|
Ictsi Jasa Prima Tbk
JK:KARW
|
-0.039x |
|
Vinvest Capital Holdings Bhd
KLSE:0069
|
-0.012x |
|
MAA Group Bhd
KLSE:1198
|
0.035x |
|
Smartiks Yazilim AS
IS:SMART
|
0.098x |
|
Snipp Interactive Inc
V:SPN
|
-0.018x |
|
Baijiayun Group Ltd
NASDAQ:RTC
|
-1.214x |
Annual Cash Flow Conversion Efficiency for ENDRA Life Sciences Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of ENDRA Life Sciences Inc from 2014 to 2025. Review ENDRA Life Sciences Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.26 Million | $-5.18 Million | -2.293x | +20.67% |
| 2024-12-31 | $2.56 Million | $-7.40 Million | -2.890x | -71.30% |
| 2023-12-31 | $5.66 Million | $-9.55 Million | -1.687x | +4.80% |
| 2022-12-31 | $7.20 Million | $-12.77 Million | -1.772x | -71.85% |
| 2021-12-31 | $10.78 Million | $-11.12 Million | -1.031x | +31.35% |
| 2020-12-31 | $7.17 Million | $-10.77 Million | -1.502x | +16.73% |
| 2019-12-31 | $4.76 Million | $-8.59 Million | -1.804x | -46.35% |
| 2018-12-31 | $6.25 Million | $-7.70 Million | -1.233x | -97.02% |
| 2017-12-31 | $5.28 Million | $-3.30 Million | -0.626x | -142.51% |
| 2016-12-31 | $-893.77K | $-1.32 Million | 1.472x | +143.72% |
| 2015-12-31 | $250.30K | $-842.73K | -3.367x | -45.87% |
| 2014-12-31 | $605.33K | $-1.40 Million | -2.308x | -- |
About ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fa… Read more